🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Content Elimination

According to the social media company, the platform has taken down violative material and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or injecting at home.

Within moments of entering one group, a seller shared contact information, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these groups, messages show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram said it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to potentially significant health risks”.